One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical foam 0.3%, and $2.5M for ZORYVE cream 0.15%; sales growth ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

READ MORE: RGU men’s football team embark on madcap Movember challenges in £10k fundraising effort READ MORE: Aberdeen's ...

Highly active disease may be suggested by a history of new ... or as a cream (PUVA) is highly effective. Systemic treatment plays a role mainly for patients with moderate to severe psoriasis ...

But dry scalp can be genetic, seasonal, or just a consequence of your hair routine—and requires its own wash-day formula ...

If your scalp’s been bugging you with that all-day itch, the best shampoo for itchy scalps can offer a temporary respite ...

"The doctors were useless, just prescribing creams that weren't working ... When Emmy started the new medication she found ...

breakthrough in treating psoriasis and eczema. The cream, called Zambesia Botanica, containing extracts of the fruit of an African tree, has been found to relieve itchiness and ease other symptoms ...